E Mingyan
Impact in
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- CAR-T cell therapy research
Papers in
-
- Circular RNAs in diseases 4
- RNA modifications and cancer 3
- Oncology 8
- Co-authors
- Anxin Gu (8 shared papers)Guohui Liu (5 shared papers)Bo Yu (5 shared papers)Yunlong He (5 shared papers)Shuang Liu (2 shared papers)Chunbo Wang (1 shared paper)Maomao Zhang (4 shared papers)Yuqi Zhang (1 shared paper)
- Journals
- International Journal of Biological Macromolecules (2 papers)Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2 papers)Journal of Clinical Oncology (2 papers)Frontiers in Pharmacology (1 paper)BMC Pharmacology and Toxicology (1 paper)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
E Mingyan
28 papers receiving 441 citations
Peers
Comparison fields: 5 of 68
- Cancer Research 133
- Oncology 93
- Cardiology and Cardiovascular Medicine 58
- Molecular Biology 189
- Immunology 47
Countries citing papers authored by E Mingyan
This map shows the geographic impact of E Mingyan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E Mingyan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E Mingyan more than expected).
Fields of papers citing papers by E Mingyan
This network shows the impact of papers produced by E Mingyan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E Mingyan. The network helps show where E Mingyan may publish in the future.
Co-authors
The 25 scholars most cited alongside E Mingyan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 67 | |
| 2 | 2024 | 61 | |
| 3 | 2020 | 46 | |
| 4 | 2021 | 45 | |
| 5 | 2016 | 40 | |
| 6 | 2007 | 23 | |
| 7 | 2019 | 23 | |
| 8 | 2021 | 23 | |
| 9 | 2015 | 22 | |
| 10 | 2021 | 16 | |
| 11 | 2008 | 12 | |
| 12 | 2023 | 10 | |
| 13 | 2020 | 10 | |
| 14 | 2012 | 9 | |
| 15 | 2019 | 8 | |
| 16 | 2024 | 7 | |
| 17 | 2023 | 4 | |
| 18 | 2020 | 4 | |
| 19 | 2020 | 3 | |
| 20 | 2023 | 3 |
About E Mingyan
E Mingyan is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Cancer Research and Surgery, having authored 31 papers that have together received 446 indexed citations. Recurring topics across this work include Circular RNAs in diseases (4 papers), Lung Cancer Treatments and Mutations (4 papers), Esophageal Cancer Research and Treatment (3 papers), RNA modifications and cancer (3 papers), Gastric Cancer Management and Outcomes (3 papers), Cancer-related molecular mechanisms research (2 papers), Chemotherapy-induced cardiotoxicity and mitigation (2 papers) and Lung Cancer Diagnosis and Treatment (2 papers). The work is most often cited by research in Cancer Research (133 citations), Oncology (93 citations), Cardiology and Cardiovascular Medicine (58 citations), Molecular Biology (189 citations) and Immunology (47 citations). E Mingyan has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Anxin Gu, Guohui Liu, Bo Yu, Yunlong He, Shuang Liu, Chunbo Wang, Maomao Zhang, Yuqi Zhang, Qiang Yao and Yongwu Li. Their work appears in journals such as International Journal of Biological Macromolecules, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, Journal of Clinical Oncology, Frontiers in Pharmacology and BMC Pharmacology and Toxicology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.